Literature DB >> 34434576

Dosimetric impact of contrast-enhanced 4d computed tomography for stereotactic body radiation therapy of hepatocelluar carcinoma.

Rose Kamal1,2, Deepak Thaper1,2, Rishabh Kumar1, Gaganpreet Singh1,3, Hanuman P Yadav2, Arun S Oinam3, Vivek Kumar1, Hitesh Sharma4.   

Abstract

BACKGROUND: A purpose of the study was to investigate the dosimetric impact of contrast media on dose calculation using average 4D contrast-enhanced computed tomography (4D-CECT) and delayed 4D-CT (d4D-CT) images caused by CT simulation contrast agents for stereotactic body radiation therapy (SBRT) of liver cases.
MATERIALS AND METHODS: Fifteen patients of liver SBRT treated using the volumetric modulated arc therapy (VMAT) technique were selected retrospectively. 4D-CECT, and d4D-CT were acquired with the Anzai gating system and GE CT. For all patients, gross target volume (GTV) was contoured on the ten phases after rigid registration of both the contrast and delayed scans and merged to generate internal target volume (ITV) on average CT images. Region of interest (ROI) was drawn on contrast images and then copied to the delayed images after rigid registration of two average CT datasets. The treatment plans were generated for contrast enhanced average CT, delayed average CT and contrast enhanced average CT with electron density of the heart overridden.
RESULTS: No significant dosimetric difference was observed in plans parameters (mean HU value of the liver, total monitor units, total control points, degree of modulation and average segment area) except mean HU value of the aorta amongst the three arms. All the OARs were evaluated and resulted in statistically insignificant variation (p > 0.05) using one way ANOVA analysis.
CONCLUSIONS: Contrast enhanced 4D-CT is advantageous in accurate delineation of tumors and assessing accurate ITV. The treatment plans generated on average 4D-CECT and average d4D-CT have a clinically insignificant effect on dosimetric parameters.
© 2021 Greater Poland Cancer Centre.

Entities:  

Keywords:  4D-CECT; HCC; HU; SBRT; VMAT; d4D-CT

Year:  2021        PMID: 34434576      PMCID: PMC8382070          DOI: 10.5603/RPOR.a2021.0075

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  17 in total

1.  Influence of intravenous contrast agent on dose calculation in 3-D treatment planning for radiosurgery of cerebral arteriovenous malformations.

Authors:  Angelika Zabel-du Bois; Benjamin Ackermann; Henrik Hauswald; Oliver Schramm; Gabriele Sroka-Perez; Peter Huber; Jürgen Debus; Stefanie Milker-Zabel
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

2.  Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer.

Authors:  D C Weber; M Rouzaud; R Miralbell
Journal:  Radiother Oncol       Date:  2001-04       Impact factor: 6.280

3.  The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer.

Authors:  Stanley L Liauw; Robert J Amdur; William M Mendenhall; Jatinder Palta; Siyong Kim
Journal:  Am J Clin Oncol       Date:  2005-10       Impact factor: 2.339

4.  4DCT Simulation With Synchronized Contrast Injection in Liver SBRT Patients.

Authors:  Joelle Helou; Aliaksandr Karotki; Laurent Milot; William Chu; Darby Erler; Hans T Chung
Journal:  Technol Cancer Res Treat       Date:  2015-03-02

5.  4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.

Authors:  A Sam Beddar; Tina Marie Briere; Peter Balter; Tinsu Pan; Naresh Tolani; Chaan Ng; Janio Szklaruk; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2008-01-14       Impact factor: 6.280

6.  Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma.

Authors:  Anil Gupta; Rishabh Kumar; Hanuman Prasad Yadav; Manik Sharma; Rose Kamal; Deepak Thaper; Prabir Banik; Shipra Gupta; Kartik Saroha; Sandeep Singh; Shiv Kumar Sarin
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-13

7.  Dosimetric comparison of dynamic conformal arc integrated with segment shape optimization and variable dose rate versus volumetric modulated arc therapy for liver SBRT.

Authors:  Deepak Thaper; Rose Kamal; Gaganpreet Singh; Arun S Oinam; Hanuman P Yadav; Rishabh Kumar; Vivek Kumar
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-20

8.  Impact of dose heterogeneity in target on TCP and NTCP for various radiobiological models in liver SBRT: different isodose prescription strategy.

Authors:  Deepak Thaper; Gaganpreet Singh; Rose Kamal; Arun S Oinam; Hanuman P Yadav; Rishabh Kumar; Vivek Kumar
Journal:  Biomed Phys Eng Express       Date:  2021-01-30

9.  Hepatic arterial phase and portal venous phase computed tomography for dose calculation of stereotactic body radiation therapy plans in liver cancer: a dosimetric comparison study.

Authors:  Jianghong Xiao; Yan Li; Qingfeng Jiang; Lan Sun; Fraser Henderson; Yongsheng Wang; Xiaoqin Jiang; Guangjun Li; Nianyong Chen
Journal:  Radiat Oncol       Date:  2013-11-09       Impact factor: 3.481

Review 10.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.